⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 1, 2003Journal of Biological ChemistryOpen Access

Control of Cardiac Growth and Function by Calcineurin Signaling

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

RVRick B. VegaAstraZeneca (Poland)

Rhonda Bassel‐DubyGeneral Cardiology

Eric N. OlsonHeart Failure & Transplant

Discussion

Loading...

Member takes

Implication

Calcineurin inhibition merits targeted hypertrophy research; clinical translation remains unproven pending prospective trials.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vega et al. (2003) studied this question.

synapsesocial.com/papers/6a204a95f8fff11fb92ed0ef https://doi.org/10.1074/jbc.r300023200

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1cis -Acting Sequences That Mediate Induction of β-Myosin Heavy Chain Gene Expression During Left Ventricular Hypertrophy due to Aortic Constriction1997 · 176 citations
2Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy2003 · 220 citations
3Impaired cardiac hypertrophic response in Calcineurin Aβ -deficient mice2002 · 239 citations
4Targeted Inhibition of Calcineurin in Pressure-overload Cardiac Hypertrophy2002 · 122 citations
5Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling2003 · 281 citations